RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-2.03%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.01B
AUM Growth
+$1.01B
(-33%)
Cap. Flow
-$433M
Cap. Flow
% of AUM
-42.73%
Top 10 Holdings %
Top 10 Hldgs %
28.64%
Holding
97
New
5
Increased
11
Reduced
69
Closed
8
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$19.9M |
| 2 |
BioNTech
BNTX
|
$14.5M |
| 3 |
Align Technology
ALGN
|
$6.54M |
| 4 |
Cytokinetics
CYTK
|
$5.34M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$5.3M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$31.6M |
| 2 |
Elevance Health
ELV
|
$25.4M |
| 3 |
McKesson
MCK
|
$25.1M |
| 4 |
Johnson & Johnson
JNJ
|
$24.8M |
| 5 |
Pfizer
PFE
|
$24.7M |
Sector Composition
| 1 | Healthcare | 98.1% |
| 2 | Industrials | 1.09% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Phathom Pharmaceuticals
PHAT
$843M
| $3.2M | 0.32% |
235,210
+49,000
| +26% | +$667K |
|
77
Biogen
BIIB
$20.8B
| $3.16M | 0.31% |
15,000
-100,000
| -87% | -$21.1M |
|
78
Phreesia
PHR
$1.81B
| $3.08M | 0.3% |
117,000
-6,465
| -5% | -$170K |
|
79
Stereotaxis
STXS
$246M
| $2.97M | 0.29% |
797,330
-2,670
| -0.3% | -$9.96K |
|
|
VRAY
80
DELISTED
ViewRay, Inc.
VRAY
| $2.88M | 0.28% |
735,000
-40,000
| -5% | -$157K |
|
81
Ionis Pharmaceuticals
IONS
$9.64B
| $2.63M | 0.26% |
71,000
-4,000
| -5% | -$148K |
|
82
ESSA Pharma
EPIX
$11.2M
| $2.54M | 0.25% |
410,923
-9,077
| -2% | -$56.1K |
|
83
MacroGenics
MGNX
$121M
| $2.53M | 0.25% |
287,081
-13,572
| -5% | -$120K |
|
|
OLK
84
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $2.47M | 0.24% |
140,000
| – | – |
|
|
GTHX
85
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.4M | 0.24% |
316,137
-8,863
| -3% | -$67.4K |
|
86
Olema Pharmaceuticals
OLMA
$432M
| $2.13M | 0.21% |
500,000
| – | – |
|
87
Rapid Micro Biosystems
RPID
$105M
| $2.04M | 0.2% |
300,000
+103,913
| +53% | +$706K |
|
|
PVLA
88
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $909K | 0.09% |
300,000
| – | – |
|
89
Annexon
ANNX
$225M
| $683K | 0.07% |
250,000
| – | – |
|
|
VCRA
90
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| – | – |
-60,000
| Closed | -$3.84M |
|
|
EPZM
91
DELISTED
Epizyme, Inc
EPZM
| – | – |
-265,000
| Closed | -$702K |
|
|
DCPH
92
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-60,000
| Closed | -$604K |
|
93
Zimmer Biomet
ZBH
$20.8B
| – | – |
-90,000
| Closed | -$11.5M |
|
|
SAGE
94
DELISTED
Sage Therapeutics
SAGE
| – | – |
-115,000
| Closed | -$4.97M |
|
95
InnovAge Holding
INNV
$509M
| – | – |
-150,000
| Closed | -$741K |
|
96
HCA Healthcare
HCA
$95.4B
| – | – |
-59,000
| Closed | -$15.2M |
|
97
FibroGen
FGEN
$48.4M
| – | – |
-200,000
| Closed | -$2.82M |
|